HOME >> MEDICINE >> NEWS
Harvard Med. School report warns of world health threat

New York---October 28, 1999-- Deadly strains of drug resistant tuberculosis are spreading rapidly and threaten to spiral out of control, according to "The Global Impact of Drug Resistant Tuberculosis", a report released today by Harvard Medical School's Program on Infectious Disease and Social Change and the Open Society Institute. The World Health Organization first sounded the TB alarm six years ago--labeling the airborne bacteria a "global emergency." But with the increasing prevalence of drug resistant strains of the disease, the epidemic has taken a chilling new direction.

In Russia, Estonia and other hotspots around the world cases of multidrug-resistant tuberculosis (MDR-TB) are reaching unprecedented levels. While TB and MDR-TB have traditionally been viewed as a scourge of the poor, the report traces the spread of MDR-TB to Western Europe and North America. The study, commissioned by philanthropist George Soros's Open Society Institute, documents drug-resistant TB in more than 100 countries.

"The rapid rise of multidrug-resistant tuberculosis is a public-health catastrophe of the first order," says the report's lead author Dr. Paul Farmer, an associate professor of social medicine at Harvard Medical School. "MDR-TB is a man-made problem. When patients stop taking or don't take enough of the right medications, they develop resistance to the drugs, and then spread new drug-resistant strains of the bacteria."

Immediate action and a massive infusion of new resources are urgently needed to bring this problem under control. While the report outlines an effective approach to the exploding epidemic, it also points out that without at least $1 billion in new funding for TB treatment in the immediate future, MDR-TB will spread to all corners of the earth.

"If new money isn't made available immediately the epidemic may become virtually impossible to contain," said Dr. Farmer. "It is only a matter of time before MDR-TB becomes a serious threat
'"/>

Contact: Michael Vachon
mvachon@sorosny.org
212-548-0668
Open Society Institute
27-Oct-1999


Page: 1 2

Related medicine news :

1. Philanthropist Paul F. Glenn launches labs for aging research at Harvard Medical School
2. Three Harvard Medical School endowed chairs named simultaneously in sleep medicine
3. Civil rights campaign issues at Harvard
4. NYU Child Study Center to honor Larry Summers, President of Harvard and Ann Tenenbaum and Tom Lee
5. Harvard chemist wins national award for creating new molecules
6. Harvard Medical School new digital library to feature MD Consult full text medical resources
7. Harvard researcher receives national award
8. UCSF-Harvard Team Reports Encouraging Results In Drug Study Of Mice With Cancer
9. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant
10. School-based smoking prevention programs ineffective
11. Mailman School of Public Health researchers develop infectious disease diagnostic tool

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Harvard Med School report warns world health threat

(Date:2/26/2015)... 2015 marks five years of being ... Caggiano! , Orthodontics is a perfect blend of ... background in biomedical engineering, his artistic talent, his extensive ... dentist allows Dr. Caggiano to create innovative approaches to ... named Orthodontic Products’ Best of 2012, a national recognition, ...
(Date:2/26/2015)... The hip resurfacing procedure at Texas Orthopedics has ... Short to resume his active lifestyle, it has improved his ... Kilimanjaro, the highest free-standing mountain in the world, in an ... late 20s, Short suffered from early onset degeneration. His condition ... bone on bone. , Then about five years ago, ...
(Date:2/26/2015)... CA (PRWEB) February 26, 2015 Beckman ... “Diversity of extracellular vesicles and their cargo in cell-to-cell ... vesicles and their relevance for cell-to-cell communication. The webinar ... March 4, 2015 at 8:00am PT. , Every cell ... extracellular vesicles (EVs) , often called “exosomes” or “microvesicles.” ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 2015 ... is a professional and in-depth study on the ... with a focus on the Chinese situation. ... are Lawton Gmbh & Co.KG, Hu-Friedy, Medisporex, Towne ... Instruments, Shuangyin, Shanghai Weirong Medical Equipment, Shuanglu, Changshu ...
(Date:2/26/2015)... 26, 2015 “ KnowNote ” was featured ... the latest and coolest mobile applications on the iOS, Android, ... host of NewsWatch, conducted the app review and shared with ... in rhythm and in tune. , Learning a musical instrument ... But what if people could take something they already know ...
Breaking Medicine News(10 mins):Health News:Dr. David Caggiano of Caggiano Orthodontics is Celebrating Five Years as an "NJ Top Dentist" ! 2Health News:Dr. David Caggiano of Caggiano Orthodontics is Celebrating Five Years as an "NJ Top Dentist" ! 3Health News:Hip Resurfacing at Texas Orthopedics Enables Patient to Climb Mt. Kilimanjaro 2Health News:Hip Resurfacing at Texas Orthopedics Enables Patient to Climb Mt. Kilimanjaro 3Health News:Beckman Coulter Webinar Series Presents Diversity of Extracellular Vesicles and Their Cargo in Cell-to-cell Communication 2Health News:Beckman Coulter Webinar Series Presents Diversity of Extracellular Vesicles and Their Cargo in Cell-to-cell Communication 3Health News:Global Hemostat Industry Data, Size and Growth Report 2015-2020 Now Available at DeepResearchReports.com 2Health News:Global Hemostat Industry Data, Size and Growth Report 2015-2020 Now Available at DeepResearchReports.com 3Health News:A Modern Way to Learn Music was Featured on NewsWatch Television on January 30, 2015 2
(Date:2/26/2015)... -- ABIVAX, a clinical stage biotech company developing ... it has dosed in New Zealand ... ABX203 which is taking place in several countries of the ... to assess whether ABX203 can deliver a significant improvement in ... load for a much longer period of time when compared ...
(Date:2/26/2015)... Medtronic, Inc. (U.S.), St. Jude Medical, ... in the Saudi Arabia , ... expected to lead the market during the period of 2014 ... player in the market, and owns a wide product portfolio ... Entera Neurostimulator are some of the most popular brands of ...
(Date:2/26/2015)... --  HeartWare International, Inc . (NASDAQ: HTWR ... support technologies that are revolutionizing the treatment of advanced ... the fourth quarter ended December 31, 2014, a 38% ... same period of 2013.  For the fiscal year 2014, ... increase compared to revenue of $207.9 million in 2013.  ...
Breaking Medicine Technology:ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 2ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 3ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 4ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 5Middle East & Africa Internal Neurostimulation/Neuromodulation Market is Expected to Reach $6.1 Million by 2019, at a CAGR of 17.9% from 2014 to 2019 2Middle East & Africa Internal Neurostimulation/Neuromodulation Market is Expected to Reach $6.1 Million by 2019, at a CAGR of 17.9% from 2014 to 2019 3Middle East & Africa Internal Neurostimulation/Neuromodulation Market is Expected to Reach $6.1 Million by 2019, at a CAGR of 17.9% from 2014 to 2019 4HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 2HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 3HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 4HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 5HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 6HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 7HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 8HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 9HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 10HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 11HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 12
Cached News: